180160-99-0 Usage
Uses
Used in Pharmaceutical Synthesis:
4-NAPHTHALEN-2-YL-PIPERIDINE is used as an intermediate in the synthesis of pharmaceutical compounds for various medical conditions. Its structural features allow for the development of potential drugs that can target specific biological pathways.
Used in Binding Assays:
As a ligand, 4-NAPHTHALEN-2-YL-PIPERIDINE is used in binding assays to study molecular interactions. Its ability to bind with certain receptors or molecules can provide insights into the mechanisms of action for potential drugs.
Used in Neurotransmitter Research:
4-NAPHTHALEN-2-YL-PIPERIDINE is being studied for its potential use as a dopaminergic or serotonergic agent. This suggests that it may have applications in the treatment of neurological disorders related to dopamine or serotonin imbalances.
Used in Biotechnology as a Fluorescent Probe:
4-NAPHTHALEN-2-YL-PIPERIDINE has been investigated for its potential as a fluorescent probe for detecting certain biomolecules. This application could be particularly useful in research and diagnostic settings, where the ability to visualize and track specific molecules is crucial.
Check Digit Verification of cas no
The CAS Registry Mumber 180160-99-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,1,6 and 0 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 180160-99:
(8*1)+(7*8)+(6*0)+(5*1)+(4*6)+(3*0)+(2*9)+(1*9)=120
120 % 10 = 0
So 180160-99-0 is a valid CAS Registry Number.
180160-99-0Relevant articles and documents
CHEMOKING RECEPTOR ANTAGONISTS
-
Page/Page column 173, (2013/03/26)
Disclosed herein are chemokine receptor antagonists of formula (I) wherein G1, X1, X2, and X3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.
Inhibitors of serotonin reuptake
-
, (2008/06/13)
This invention provides compounds and a method for the inhibition of serotonin reuptake in mammals.
